南京正大天晴制药有限公司(Nanjing Zhengda Tianqing Zhiyao Youqian Gongsi)
Set up in 2001, Nanjing Chia Tai Tianqing Pharmaceutical Co Ltd is one of the most important subsidiaries of Sino Biopharmaceutical Limited, a company listed on the Hong Kong Stock Exchange under the code 1177.
Chia Tai Tianqing Pharmaceutical Group Co Ltd (CTTQ) is among the top 30 pharmaceutical companies in China, and expects to be more active in international business with GMP basis approval from the European Health Authority and US Food and Drug Administration (FDA). It also has specialized and diversified products in the pipeline.
The company specializes in hepatitis therapy, oncology therapy, and respiratory therapy.
Headquarters address: No 99 Hengguang Road, Nanjing Economic and Technological Development Zone
Official website: www.njcttq.com (Chinese)